Looking Ahead to ESMO 2026: Supporting the Next Generation of Oncology Innovation
As ESMO 2026 approaches, oncology remains one of the most dynamic areas of drug development. From precision medicine and antibody-drug conjugates to radiopharmaceuticals and AI-driven…
Find out more